These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12437480)

  • 41. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
    Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
    Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacogenomics of Alzheimer's disease.
    Crentsil V
    Ageing Res Rev; 2004 Apr; 3(2):153-69. PubMed ID: 15177052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrative systems biology approaches in asthma pharmacogenomics.
    Dahlin A; Tantisira KG
    Pharmacogenomics; 2012 Sep; 13(12):1387-404. PubMed ID: 22966888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Challenges and opportunities in pharmacogenomics and therapeutics.
    Kane MD; Summers KH
    J Manag Care Pharm; 2007 Sep; 13(7):607-8. PubMed ID: 17874867
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacogenomics in clinical practice and drug development.
    Harper AR; Topol EJ
    Nat Biotechnol; 2012 Nov; 30(11):1117-24. PubMed ID: 23138311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacogenomics and personalized medicine--a global reality check.
    Wong SH
    Clin Chem Lab Med; 2007; 45(7):799-800. PubMed ID: 17617018
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacogenomics: unlocking the human genome for better drug therapy.
    McLeod HL; Evans WE
    Annu Rev Pharmacol Toxicol; 2001; 41():101-21. PubMed ID: 11264452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural pharmacogenomics: the answer to antimicrobial drug resistance?
    Taylor PW; Stapleton PD
    Drug Discov Today; 2003 Feb; 8(3):110-1. PubMed ID: 12568777
    [No Abstract]   [Full Text] [Related]  

  • 50. The use of animal models in expression pharmacogenomic analyses.
    Rothberg BE
    Pharmacogenomics J; 2001; 1(1):48-58. PubMed ID: 11913726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy.
    El-Hachem N; Gendoo DMA; Ghoraie LS; Safikhani Z; Smirnov P; Chung C; Deng K; Fang A; Birkwood E; Ho C; Isserlin R; Bader GD; Goldenberg A; Haibe-Kains B
    Cancer Res; 2017 Jun; 77(11):3057-3069. PubMed ID: 28314784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression-driven reverse engineering of targeted imaging and therapeutic agents.
    Gillies RJ; Hruby VJ
    Expert Opin Ther Targets; 2003 Apr; 7(2):137-9. PubMed ID: 12667092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Candidate gene selection in pharmacogenomics: biology leads the way.
    Watters JW; McLeod HL
    Pharmacogenomics; 2004 Dec; 5(8):1019-22. PubMed ID: 15584871
    [No Abstract]   [Full Text] [Related]  

  • 54. "Personalised" drug therapy could be near.
    Larkin M
    Lancet; 1998 Jun; 351(9120):1937. PubMed ID: 9654273
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacogenomics: opening new vistas in pharmacotherapy.
    Freeman TR
    J Am Pharm Assoc (Wash); 2001; 41(4):629-30. PubMed ID: 11486992
    [No Abstract]   [Full Text] [Related]  

  • 56. The virtuous cycle of human genetics and mouse models in drug discovery.
    Nadeau JH; Auwerx J
    Nat Rev Drug Discov; 2019 Apr; 18(4):255-272. PubMed ID: 30679805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The progress of COST B1--a European collaboration on the study of interindividual differences in drug disposition and action. Organization for European Co-operation in the field of Science and Technical Research.
    Bechtel P; Alván G
    Eur J Clin Pharmacol; 1998 Oct; 54(8):585-7. PubMed ID: 9860143
    [No Abstract]   [Full Text] [Related]  

  • 58. A framework for comparing phenotype annotations of orthologous genes.
    Bodenreider O; Burgun A
    Stud Health Technol Inform; 2010; 160(Pt 2):1309-13. PubMed ID: 20841896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacogenomics and drug development.
    Guo Y; Shafer S; Weller P; Usuka J; Peltz G
    Pharmacogenomics; 2005 Dec; 6(8):857-64. PubMed ID: 16296948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variation in coding regions between and within commonly used inbred rat strains.
    Smits BM; van Zutphen BF; Plasterk RH; Cuppen E
    Genome Res; 2004 Jul; 14(7):1285-90. PubMed ID: 15231744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.